共 40 条
- [11] Exploratory Analysis of Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma Who Have Failed Prior PD-1/PD-L1 Checkpoint BlockadeCANCERS, 2020, 12 (10) : 1 - 13Aoki, TomokoKudo, MasatoshiUeshima, KazuomiMorita, MasahiroChishina, HirokazuTakita, MasahiroHagiwara, SatoruIda, HiroshiMinami, YasunoriTsurusaki, MasakatsuNishida, Naoshi
- [12] Paradoxically functioning onco-miR-155 and the tumor suppressor miR-194 consensus on PD-L1 immune checkpoint upregulation via MALAT-1 and XIST in hepatocellular carcinomaJOURNAL OF HEPATOLOGY, 2018, 68 : S610 - S611Atwa, S.Hosny, K.Handoussa, H.El Tayebi, H.
- [13] Ex Vivo PD-L1/PD-1 Pathway Blockade Reverses Dysfunction of Circulating CEA-Specific T Cells in Pancreatic Cancer PatientsCLINICAL CANCER RESEARCH, 2017, 23 (20) : 6178 - 6189Chen, YuanXue, Shao-AnBehboudi, ShahriarMohammad, Goran H.Pereira, Stephen P.Morris, Emma C.
- [14] PD-1 and PD-L1 upregulation promotes CD8+ T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patientsINTERNATIONAL JOURNAL OF CANCER, 2011, 128 (04) : 887 - 896Shi, FengShi, MingZeng, ZhenQi, Rui-ZhaoLiu, Zhen-WenZhang, Ji-YuanYang, Yong-PingTien, PoWang, Fu-Sheng
- [15] Gemcitabine-facilitated modulation of the tumor microenvironment and PD-1/PD-L1 blockade generate a synergistic antitumor effect in a murine hepatocellular carcinoma modelCLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (04)Wang, HuaHe, XueFang, DongWang, XianGuan, JingShi, Zhen-WangChen, Xi
- [16] Overcoming the resistance of hepatocellular carcinoma to PD-1/PD-L1 inhibitor and the resultant immunosuppression by CD38 siRNA-loaded extracellular vesiclesONCOIMMUNOLOGY, 2023, 12 (01):Deng, JunKe, Hui
- [17] TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulationNATURE CANCER, 2024, 5 (12) : 1834 - 1851Nutsch, KatherineBanta, Karl L.Wu, Thomas D.Tran, Charles W.Mittman, StephanieDuong, EllenNabet, Barzin Y.Qu, YanWilliams, KatherineMueller, SorenPatil, Namrata S.Chiang, Eugene Y.Mellman, Ira
- [18] Exosomes derived from hepatocellular carcinoma inhibit CD4+ and CD8+ T cell function through the PD-1/PD-L1 pathwayINTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (05): : 5333 - 5340Li, PengpengLiu, DianxingChen, JunmaoWu, JinghuaZhang, GuozhiWang, ChangyouYu, XiangyangChen, JianliHu, BeibeiLi, Changzai
- [19] Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulationScientific Reports, 11Alexander RobertsLindsay BentleyTina TangFay StewartChiara PalliniJoel JuvvanapudiGraham R. WallaceAlison J. CooperAaron ScottDavid ThickettSebastian T. LuggHollie BancroftBridget HemmingCharlotte FerrisGerald LangmanAndrew RobinsonJoanne ChapmanBabu NaiduThomas PinkneyGraham S. TaylorKristian BrockZania StamatakiCatherine A. BradyS. John CurnowJohn GordonOmar QureshiNicholas M. Barnes
- [20] Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulationSCIENTIFIC REPORTS, 2021, 11 (01)Roberts, AlexanderBentley, LindsayTang, TinaStewart, FayPallini, ChiaraJuvvanapudi, JoelWallace, Graham R.Cooper, Alison J.Scott, AaronThickett, DavidLugg, Sebastian T.Bancroft, HollieHemming, BridgetFerris, CharlotteLangman, GeraldRobinson, AndrewChapman, JoanneNaidu, BabuPinkney, ThomasTaylor, Graham S.Brock, KristianStamataki, ZaniaBrady, Catherine A.Curnow, S. JohnGordon, JohnQureshi, OmarBarnes, Nicholas M.